Home » Topics » BioWorld Science

BioWorld Science
RSS

EGFR tyrosine kinase inhibitor from UCLA crosses the blood-brain barrier

Aug. 27, 2018

Lawrence Livermore National Laboratory develops nerve agent antidote LLNL-02

Aug. 27, 2018

Koligo introduces Kyslecel to preserve insulin secretory capacity after total pancreatectomy

Aug. 27, 2018

Nilotinib improves biomarkers of Parkinson's disease in phase II study

Aug. 27, 2018

Unexpected asthma mechanism changes targeting calculus

Aug. 27, 2018

Brain-on-three-chips includes BBB

Aug. 27, 2018

Parkin, PINK keep inflammation pout of the red zone

Aug. 27, 2018

Kinase interplay prevents ALS

Aug. 27, 2018

FDA approves cobas EGFR Mutation Test v2 as companion diagnostic test with Iressa

Aug. 24, 2018

bluebird bio and Gritstone Oncology establish cancer cell therapy collaboration

Aug. 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...